Browse All

Current Filters

CLEAR FILTER x

TITLE

Real World Data in 15,634 Patients with Amyotrophic Lateral Sclerosis (ALS) to Study the Effect of Immunotherapies

Real-world Clinical Outcomes with Eculizumab and Ravulizumab in Anti–Aquaporin-4 Antibody–Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results From the Global NMO SPOTLIGHT Registry

Recognize, Escalate, Survive: A Rare Case of Immune Checkpoint Inhibitor-induced Myasthenia Gravis, Myocarditis and Myositis Overlap Syndrome Triggered by Pembrolizumab

Recovery and Rechallenge after Neurological Immune-related Adverse Events from Immune Checkpoint Inhibitors